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Xanthogranulomatous Pancreatitis Combined with Intraductal 
Papillary Mucinous Carcinoma In Situ
Xanthogranulomatous lesion is a rare condition in which lipid-laden histiocytes are 
deposited at various locations in the body. Xanthogranulomatous pancreatitis (XGP) 
associated with an intraductal papillary mucinous tumor (IPMT) is extremely rare. In this 
study, we described a case of XGP associated with IPMT and include a review of the 
literature. A pancreatic cystic mass was detected in a 72-yr-old woman by abdominal 
computed tomography. Pylorus-preserving pancreaticoduodenectomy was performed and 
diagnosis of XGP combined with intraductal papillary mucinous carcinoma in situ was 
made. After 13 months of follow-up, the patient is in good health without any evidence 
of tumor recurrence. Although XGP associated with IPMT is rare, we suggest that such 
cases should be brought to the attention of clinical investigators, as it may produce clinical 
features that mimic pancreatic cancer.
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INTRODUCTION
Xanthogranulomatous lesion is a rare condition in which lipid-
laden histiocytes are deposited at various locations in the body. 
Xanthogranulomatous pancreatitis (XGP) associated with an 
intraductal papillary mucinous tumor (IPMT) is extremely rare. 
To our knowledge only two cases have been reported in the 
English-language literature and this is the first reported case in 
Korea (1, 2). 
CASE REPORT
A 72-yr-old woman was referred to our hospital on April 26, 2009 
with incidentally detected pancreatic cystic mass. She visited 
local clinic due to uncontrolled diabetes mellitus which had 
been treated since 2 yr ago. She had lost 7-kg of body weight 
over the last 3 months. The physical examination of the patient 
was unremarkable. The blood count and serum chemistry, in-
cluding amylase, were within normal limits. Carcinoembryonic 
antigen (CEA), carbohydrate antigen 19-9 (CA19-9) were also 
normal. Abdominal computed tomography (CT) scan demon-
strated diffuse dilatation of main pancreatic duct with multifo-
cal cysts in pancreatic parenchyma. There was no evidence of 
calcifying chronic pancreatitis such as pancreatic calcification 
or multifocal stricture of pancreatic duct. Positron emission to-
mography (PET) CT showed no fluorodeoxyglucose (FDG) up-
taked lesion in pancreas. On magnetic resonance cholangiopan-
creatography (MRCP), main pancreatic duct was tortuously di-
lated and multifocal variable sized cysts were accompanied in 
adjacent pancreatic parenchyma, which was indicative of mixed 
type of intraductal papillary mucinous neoplasm involving both 
main and branch duct with retention cysts (Fig. 1A). On fat sup-
pressed T1-weighted image and contrast-enhanced arterial phase 
MRI, the signal intensity of pancreatic neck portion was focally 
decreased compared to that of normal pancreas, suggesting in-
flammatory reaction due to ductal obstruction (Fig. 1B). How-
ever, any definite pancreatic mass was not identified. At lapa-
rotomy, intraoperative ultrasound (IOUS) was performed, and 
showed the cystic mass extended to the tail of the pancreas. Py-
lorus-preserving pancreaticoduodenectomy was performed, 
and on gross examination, the pancreatic duct showed multi-
locular cystic formations filled with mucus in the head and un-
cinate process. Very close to the dilated cystic lesion, a yellow 
nodular lesion was found to be 1.5×1 cm in size (Fig. 2A). Histo-
logically, these dilated ducts were lined by papillary and micro-
papillary columnar mucous cells with severe dysplastic chang-
es in the absence of stromal invasion, suggesting the presence 
of papillary mucinous carcinoma in situ (Fig. 2B). The nodular Kim YN, et al.  •  Combined XGP and IPMT
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lesion was composed of an aggregation of many foam cells, lym-
phocytes, and plasma cells (Fig. 2C). Immunohistochemistry 
for CD68 confirmed that the majority of foamy cells were lipid 
laden macrophages (Fig. 2D). Final diagnosis of xanthogranu-
lomatous pancreatitis combined with intraductal papillary mu-
cinous carcinoma in situ was made. After 13 months of follow-
Fig. 1. Images of the pancreatic lesions. (A) The coronal single-projection thick-section rapid acquisition with relaxation enhancement MR cholangiography showed a tortuously 
dilated main pancreatic duct with adjacent variable sized multiple cysts (arrows). (B) An axial, pancreatic phase, three-dimensional MRI after the administration of gadopentetate 
dimeglumine showed an area of ill-defined, focally decreased signal intensity in the pancreatic neck portion (arrows).
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Fig. 2. Pathologic findings of the pancreatic lesions. (A) Macroscopically, the pancreatic main duct was dilated, and variable sized-mucin containing cysts and parenchymal 
yellow nodular lesions were observed (arrows). (B) Microscopically, dilated ducts that were epithelized by papillary and micropapillary columnar mucous cells with severe 
dysplastic change were seen (H&E, ×200). (C) The surrounding pancreatic tissue was atrophic and infiltrated with many foamy macrophages, lymphocytes and plasma cells 
(H&E, ×100). (D) Positive CD 68 immunohistochemical staining of the foam cells (×200).
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Table 1. Clinicopatholgic features of xanthogranulomatous pancreatitis associated with intraductal papillary mucinous tumor
Cases Age/Gender Symptom Procedure Associated lesion XGP lesion
Iso et al. (1) 82/M Weight loss Distal pancreatectomy  
with splenectomy 
Intraductal papillary  
mucinous adenoma
Pancreas, spleen
Kamitani et al. (2) 82/M Left epigastric pain
Pancreatic cystic mass
Distal pancreatectomy  
with splenectomy
Partial gastrectomy
Intraductal papillary  
mucinous adenoma without 
malignant change
Pancreas, extended  
into gastric wall
Present case 72/F Weight loss
Pancreatic cystic mass
Pylorus preserving
pancreaticoduodenectomy
Intraductal papillary  
mucinous carcinoma in situ
Pancreas
XGP, xanthogranulomatous pancreatitis.
up, the patient is in good health without any evidence of tumor 
recurrence.
 
DISCUSSION
Xanthogranulomatous lesion is characterized by an aggregation 
of foamy histiocytes and inflammatory cells. This lesion is con-
sidered as a rare variant of chronic inflammation but has been 
well documented in the gallbladder (3). Xanthogranulomatous 
pancreatitis associated with IPMT is an extremely rare inflam-
matory condition. To our knowledge, this is the third case that 
has been reported of xanthogranulomatous pancreatitis com-
bined with intraductal papillary mucinous tumor being treated 
with operation (Table 1) (1, 2). Although xanthogranulomatous 
lesion in the pancreas is a benign condition, excessive surgical 
resections used to be done in most cases, because of difficulty 
in distinguishing their condition from pancreatic cancer (1). 
These characteristic features were described better in the litera-
ture about xanthogranulomatous cholecystitis and pyelone-
phritis (3, 4). In most cases, XGP are clinically and radiologically 
confused with the carcinoma of the pancreas, because the xan-
thogranulomatous lesion simulates a malignant tumor, appear-
ing as a poorly defined, yellow, nodular mass and has neoplasm-
like properties being capable of local tissue invasion and destruc-
tion (1, 2). However, in our case, there was no evidence of any 
definite mass formation in pancreas based on CT and PET/CT 
as well as MRI, which was not consistent with macroscopic find-
ings showing nodular mass in surgically resected specimen. We 
found ill-defined focal decreased signal intensity in pancreas 
neck on unenhanced- and enhanced T1-weighted image. This 
area corresponded to the xanthogranulomatous lesion on patho-
logic correlation. We considered this lesion as early inflamma-
tory reaction of XGP caused by ductal obstruction with mucin 
leakage. The disagreement between imaging and pathologic 
findings could be explained by relatively long interval between 
time of imaging acquisition and operation (35 days). We specu-
lated that xanthogranulomatous inflammation in our case fully 
developed after imaging study. Clinically, as XGP may resemble 
pancreatic carcinoma, differentiation is essential by means of 
intraoperative histological examination to ensure optimal sur-
gical treatment.
  Although the mechanism leading to this condition remains 
unclear, obstructive conditions and infection is commonly con-
sidered to be an important factor in xanthogranulomatous in-
flammation (3-5). In the xanthogranulomatous cholecystitis and 
xanthogranulomatous pyelonephritis, previous reports have 
suggested that obstructed lesion, including stone or tumor, in-
duce extravasation of bile juice or urine. It starts as an initial 
acute inflammatory process followed by a granulomatous reac-
tion and then a cellular-type immulogic response (3). Iyer et al. 
(6) have reported that obstruction of pancreatic ducts by stone 
followed by secondary bacterial infection had initiated XGP. In-
traductal papillary mucinous tumor of the pancreas is a rare 
pancreatic cystic neoplasm that arises from the epithelial lining 
of the main pancreatic duct and/or the branch pancreatic ducts 
and secrets a thick mucin, which leads to ductal dilatation and 
obstruction. We speculated that mucin produced by IPMT in-
creased the intraductal and intracystic pressure and that a leak-
age of mucin into the pancreatic parenchyma produced the 
xanthogranulomatous changes. Kamitani et al. also reported 
that increased the intraductal pressure by the mucin produced 
by IPMT and a subsequent leak of mucin induced the XGP in 
association with IPMT (2). 
  In the fact of pancreatic lesions, including pancreatic tumors, 
pancreatitis, and other lesions that produced ductal obstruction 
are common, it is unclear why xanthogranulomatous pancre-
atitis is so rare. Although it is difficult to elucidate the exact un-
derlying mechanisms, accumulation of cases and associated 
findings should enhance the understanding of the XGP. Although 
XGP associated with IPMT is rare, we suggest that such cases 
should be brought to the attention of clinical investigators, as it 
may produce clinical features that mimic pancreatic cancer. 
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